Results
72,389 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 |  Kevin HernRJoint | PONTOTOC CNTY OKLA EDL FACS AUTH 5.000% MAT 09/01/2028 Purchase | BUY | $50K – $100K |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 34 | Kevin HernRJoint | PONTOTOC CNTY OKLA EDL FACS AUTH 5.000% MAT 09/01/2028 Purchase | BUY | $50K – $100K |
| Oct 13, 2026 traded Sep 21, 2026 |
| 33 | Politis ChristosDirector |  BAFNBayFirst Financial Corp.Other acquisition or disposition | J | $153K 43.7K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 33 | Berset Mark SDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $170K 48.7K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 33 | Berset Mark SDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $57K 16.2K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 33 | Spoor Bradly WilliamDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $77K 21.9K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 33 | Deloach Dennis Reppard IIIDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $118K 33.6K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 32 | Kevin HernRJoint |  CBChubb LtdSale | SELL | $1,001 – $15K | Oct 13, 2026 traded Sep 23, 2026 |
| 31 | Lehman Kenneth RDirector, 10% Owner | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $2.62M 749.5K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 30 | Novel Inspiration International Co., Ltd.10% Owner |  IRIXIRIDEX CORPOther acquisition or disposition | J | — 146.3K sh | Oct 13, 2026 traded Oct 2, 2026 |
| 30 | Oliver Robin LeighDirector, COO | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $39K 11.0K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 30 | Spoor Bradly WilliamDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $11K 3,021 sh | Oct 13, 2026 traded Oct 8, 2026 |
| 30 | Berset Mark SDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $23K 6,596 sh | Oct 13, 2026 traded Oct 8, 2026 |
| 30 | McKim Scott JosephEVP, Chief Financial Officer | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $7,721 2,206 sh | Oct 13, 2026 traded Oct 8, 2026 |
| 30 | Zipperian Barbara JDirector | BAFNBayFirst Financial Corp. Other acquisition or disposition | J | $18K 5,096 sh | Oct 13, 2026 traded Oct 8, 2026 |
| 28 | Gonzalez Luis ADirector |  AVOMission Produce, Inc.Open-market purchase | BUY | $247K 22.0K sh | Oct 13, 2026 traded Oct 12, 2026 |
| 28 | Kevin HernRJoint | TULSA OKLA MET UTIL AUTH UTIL REV UTIL 3.000% MAT 4/1/2029 Purchase | BUY | $15K – $50K | Oct 13, 2026 traded Sep 18, 2026 |
| 28 | Kevin HernRJoint | MAYES CNTY OKLA PUB FACS AUTH REV 3.000% MAT 9/1/2027 Purchase | BUY | $15K – $50K | Oct 13, 2026 traded Sep 18, 2026 |
| 28 | Kevin HernRJoint | GRADY CNTY OKLA SCH FIN AUH EDL FACS 5.000% MAT 9/1/2033 Purchase | BUY | $15K – $50K | Oct 13, 2026 traded Sep 18, 2026 |
| 28 | Kevin HernRJoint | OKLAHOMA DEPT TRANSN REV GAN SER 2018 A 5.000% MAT 9/1/2033 Purchase | BUY | $15K – $50K | Oct 13, 2026 traded Sep 21, 2026 |
| 27 | Toor Ajaypreet SinghChief Financial Officer |  NUCLEagle Nuclear Energy Corp.Grant or award | A | — 63.0K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 27 | Mirsaeedi-Farahani KeyvanDirector |  ADGMAdagio Medical Holdings, Inc.Other acquisition or disposition | J | — 12.8K sh | Oct 13, 2026 traded Sep 27, 2024 |
| 27 | Ropa Bethany LoganDirector |  EGPEASTGROUP PROPERTIES INCGrant or award | A | — 474 sh | Oct 13, 2026 traded Oct 8, 2026 |
| 27 | Goldmeier Brian YaleDirector | NUCLEagle Nuclear Energy Corp. Grant or award | A | — 28.1K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 27 | Kobler Michael HelmutDirector | NUCLEagle Nuclear Energy Corp. Grant or award | A | — 28.1K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 27 | Lipton Jeffrey HerschelDirector | NUCLEagle Nuclear Energy Corp. Grant or award | A | — 237.5K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 27 | Frakes James BDirector, CFO/CEO |  AEMDAETHLON MEDICAL INCGrant or award | A | — 42.0K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 26 | Kevin HernRJoint |  MRSHMARSH & MCLENNAN COMPANIES, INC.Sale | SELL | $50K – $100K | Oct 13, 2026 traded Sep 23, 2026 |
| 26 | Kevin HernRJoint | MRSHMARSH & MCLENNAN COMPANIES, INC. Partial sale | SELL | $50K – $100K | Oct 13, 2026 traded Sep 17, 2026 |
| 25 | Kevin HernRJoint |  ROKROCKWELL AUTOMATION, INCPartial sale | SELL | $15K – $50K | Oct 13, 2026 traded Sep 17, 2026 |
| 25 | Kevin HernRJoint |  LINLINDE PLCPartial sale | SELL | $15K – $50K | Oct 13, 2026 traded Sep 17, 2026 |
| 25 | Kevin HernRJoint |  SBUXSTARBUCKS CORPSale | SELL | $15K – $50K | Oct 13, 2026 traded Sep 23, 2026 |
| 24 | Kevin HernRJoint |  CVXCHEVRON CORPPartial sale | SELL | $15K – $50K | Oct 13, 2026 traded Sep 23, 2026 |
| 24 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder |  HNGEHinge Health, Inc.Open-market sale · 10b5-1 plan | SELL | $4.16M 39.9K sh | Oct 13, 2026 traded Oct 12, 2026 |
| 24 | Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder | HNGEHinge Health, Inc. Open-market sale · 10b5-1 plan | SELL | $6.21M 60.0K sh | Oct 13, 2026 traded Oct 12, 2026 |
| 23 | Mukhija Manavdeep SinghDirector, CEO and Chairman | NUCLEagle Nuclear Energy Corp. Grant or award | A | — 183.3K sh | Oct 13, 2026 traded Oct 8, 2026 |
| 23 | Lynch Thomas P.See Remarks |  BLLNBillionToOne, Inc.Option exercise | M | $69K 8,000 sh | Oct 13, 2026 traded Oct 8, 2026 |
| 23 | Kevin HernRJoint |  DVNDEVON ENERGY CORP/DESale | SELL | $50K – $100K | Oct 13, 2026 traded Sep 23, 2026 |
| 23 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $4.92M 21.9K sh | Oct 13, 2026 traded Oct 9, 2026 |
| 22 | King Ryan ADirector, Co-Founder |  CHYMChime Financial, Inc.Open-market sale · 10b5-1 plan | SELL | $1.47M 50.0K sh | Oct 13, 2026 traded Oct 9, 2026 |
| 21 | Aguirre Jarrad MattieuChief Medical Officer |  LYELLyell Immunopharma, Inc.Open-market sale | SELL | $3,642 422 sh | Oct 13, 2026 traded Oct 12, 2026 |